{Reference Type}: Journal Article
{Title}: Rethinking the use of germline CHEK2 mutation as a marker for PARP inhibitor sensitivity.
{Author}: Hayman TJ;
{Journal}: JNCI Cancer Spectr
{Volume}: 8
{Issue}: 4
{Year}: 2024 Jul 1
暂无{DOI}: 10.1093/jncics/pkae045